Abdurrahman Işıkdoğan
Abdurrahman Işıkdoğan publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Cancer Research, on topics such as Colorectal Cancer Treatments and Studies, Lung Cancer Treatments and Mutations and Breast Cancer Treatment Studies.
- World rank
- #7,585,982 of 7,710,434 ranked researchers
- Rank in Türkiye
- #112,717 of 117,622
- Works
- 281
- Citations
- 2.1k
- Citations per work
- 7.3
What does Abdurrahman Işıkdoğan research?
Abdurrahman Işıkdoğan's work is mostly in Medicine (56%), Biochemistry, Genetics and Molecular Biology (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences15856.2%
- Medicine15856.2%
- Everything else9533.7%
- Life Sciences2810.1%
- 1Oncology27% of their works
- 2Pulmonary and Respiratory Medicine20% of their works
- 3Cancer Research6% of their works
- 4Surgery5% of their works
- 5Molecular Biology5% of their works
- 6Pathology and Forensic Medicine4% of their works
Research topics
Which keywords describe Abdurrahman Işıkdoğan's research?
The keywords of their largest research topics: Chemotherapy, Molecular Subtypes, Clinical Trials, Targeted Therapy, Clinical Practice Guidelines, Survival Analysis, Radiotherapy and Adjuvant Therapy.
- Lung Cancer
- CT Screening
- Cancer of Unknown Primary
- Endoscopic Resection
- Chemotherapy-Induced Peripheral Neuropathy
- Breast Tumours
- ALK Inhibitors
- KRAS Mutations
- Adjuvant Therapy
- Survival Analysis
- Targeted Therapy
- Molecular Subtypes
- Chemotherapy
- Clinical Trials
- Clinical Practice Guidelines
- Radiotherapy
- Cetuximab
- Metastasis
- EGFR Mutations
- Gene Expression
- Taxanes
- Gastric Cancer
- Tissue of Origin
- Genomic Profiles
- Small-Cell Lung Cancer
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 25 words, with their numbers
- Chemotherapy994 topics
- Molecular Subtypes672 topics
- Clinical Trials532 topics
- Targeted Therapy532 topics
- Clinical Practice Guidelines502 topics
- Survival Analysis502 topics
- Radiotherapy472 topics
- Adjuvant Therapy412 topics
- Cetuximab391 topic
- KRAS Mutations391 topic
- Metastasis392 topics
- ALK Inhibitors341 topic
- EGFR Mutations341 topic
- Breast Tumours281 topic
- Gene Expression281 topic
- Chemotherapy-Induced Peripheral Neuropathy251 topic
- Taxanes251 topic
- Endoscopic Resection221 topic
- Gastric Cancer221 topic
- Cancer of Unknown Primary201 topic
- Tissue of Origin201 topic
- CT Screening191 topic
- Genomic Profiles191 topic
- Lung Cancer191 topic
- Small-Cell Lung Cancer191 topic
Where does Abdurrahman Işıkdoğan work?
Abdurrahman Işıkdoğan's main affiliation in the publication record is Dicle University, Türkiye.
How many publications and citations does Abdurrahman Işıkdoğan have?
OpenAlex counts 281 works and 2,065 citations for Abdurrahman Işıkdoğan, an h-index of 25, ranking #7,585,982 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Abdurrahman Işıkdoğan
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Abdurrahman Işıkdoğan. Posts are plain text and can be reported.